On May 15th (the eve of the 61st World Health Assembly), patient representatives from around the world gathered in Geneva to voice their concerns and provide recommendations on the draft plan of action as proposed by the WHO’s Intergovernmental Working Group on Innovation and Public Health (IGWG).
The following audio recordings from the patient meeting detail the key concerns and recommendations:
Introduction
Commentary from Durhane Wong-Rieger, Consumer Advocare Network (Canada) – 10 minutes
[odeo=http://odeo.com/audio/19206423/view]
Access to Medicines
Commentary from Regina Kamoga, Community Health and Information Network (Uganda) – 6 minutes[odeo=http://odeo.com/audio/19204143/view]
Counterfeit Drugs
Commentary from Reverend Anthony Ojeh (Nigeria) – 7 minutes[odeo=http://odeo.com/audio/19204173/view]
Need for Strong Regulatory Environment
Commentary from K.P. Tsang, Retina Hong Kong (China) – 7 minutes[odeo=http://odeo.com/audio/19204193/view]
Importance of IP
Commentary from Virginia Ladd, American Autoimmune Related Diseases Association (U.S.A.) – 7 minutes[odeo=http://odeo.com/audio/19204203/view]
Conclusion
Commentary from Durhane Wong-Rieger, Consumer Advocare Network (Canada) – 3 minutes[odeo=http://odeo.com/audio/19204253/view]
Filed under: IGWG Tagged: | Counterfeit drugs, IGWG, Innovation
